An overview of the global medical cannabis market, highlighting its rapid growth driven by legislative reforms, increasing research, and patient acceptance.

While North America currently leads, Europe, particularly Germany, is identified as a major growth engine due to recent law changes significantly boosting patient access and imports, despite challenges like reimbursement, physician education, and supply chain complexities.

The analysis details market size variations, evolving product preferences (favoring extracts and precise dosing), primary therapeutic uses, and the significant hurdles posed by regulatory fragmentation, banking restrictions, and competition from the illicit market.